Skip to main content

Table 3 Isolates were tested against antibiotics by disc diffusion

From: Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China

Isolate no. SCF TZP CAZ CRO FEP ATM IPM MEM LEV CIP AK DO TGC PB TOB Phenotype/MBL
1 R R R R R R R R R R R R S S R XDR/Neg
2 R R R R R R R R R R R R S S R XDR/Neg
3 R R R R R R R R R R R R S S R XDR/Neg
4 R R R R R R R R R R R R I S R XDR/Neg
5 R R R R R R R R R R R R I S R XDR/Neg
6 R R R R R R R R R R S R I S S MDR/Neg
7 R R R R R R R R R R R R I S R XDR/Neg
8 R R R R R R R R R R R R I S R XDR/Neg
9 R R R R R R R R R R R R I S R XDR/Neg
10 R R R R R R R R R R R R I S R XDR/Neg
11 R R R R R R R R R R R R I S R XDR/Neg
12 R R R R R R R R R R S R I S S MDR/Neg
13 R R R R R R R R R R R R I S R XDR/Neg
14 S R R R R R I I R R R R S S R MDR/Neg
15 R R R R R R R R R R R R I S R XDR/Neg
16 R R R R R R R R R R R R R S R XDR/Neg
17 R R R R R R R R R R R R I S R XDR/Neg
18 R R R R R R R R R R R R I S R XDR/Neg
19 R R R R R R R R R R R R I S R XDR/Neg
20 I R R R R R R R R R R I S S R XDR/Neg
21 R R R R R R R R R R R R R S R XDR/Neg
22 R R R R R R R R R R S R R S S MDR/Neg
23 I R R R R R R R R R R R S S R XDR/Neg
24 S R R R R R S S R R S R I S S MDR/Neg
25 R R R R R R R R R R R R S S R XDR/Neg
26 R R R R R R R R R R R R S S R XDR/Neg
27 R R R R R R S I R R R R I S R MDR/Neg
28 I R R R R R R R R R R R S S R XDR/Neg
29 I R R R R R R R R R R I S S R XDR/Neg
30 R R R R R R R R R R R R I S R XDR/Neg
31 R R R R R R R R R R R R I S R XDR/Neg
32 I R R R I R S S R R R I I S R MDR/Neg
33 R R R R R R R R R R R R I S R XDR/Neg
34 R R R R R R R R R R R R I S R XDR/Neg
35 R R R R R R R R R R R R I S R XDR/Neg
36 I R R R R I R R R R R S S S R MDR/Neg
37 R R R R R R R R R R R R I S R XDR/Neg
38 R R R R R R R R R R R R I S R XDR/Neg
39 R R R R R R R R R R R I S S R XDR/Pos
40 R R R R R R R R R R R R I S R XDR/Neg
41 I R R R R R S I R R R R R S R MDR/Neg
42 I S R R R R S S I R R I R S R MDR/Neg
Susceptible (%) 2.4 2.4 0.0 0.0 0.0 0.0 11.9 7.1 0.0 0.0 9.5 0.0 28.6 100.0 9.5 -
  1. Metallo-β-lactamase was detected by MBL Etest.
  2. R, resistance; S, sensitivity; I, intermediate; XDR, extensively drug-resistant; MDR, multidrug-resistant; MBL, metallo-β-lactamase; Pos, positive; Neg, negative; PB, polymyxin B (300 units); TGC, tigecycline (15 μg); IPM, imipenem (10 μg); AK, amikacin (30 μg); TOB, tobramycin (10 μg); MEM, meropenem (10 μg); TZP, piperacillin/tazobactam (100/10 μg); SCF, cefoperazone/sulbactam (70/35 μg); CAZ, ceftazidime (30 μg); CRO, ceftriaxone (30 μg); FEP, cefepime (30 μg); ATM, aztreonam (30 μg); LEV, levofloxacin (5 μg); CIP, ciprofloxacin (5 μg); DO, doxycycline (30 μg).